Enosi Life Sciences

Early Stage

Drug research and development company

Analytics

Raised to Date: Raised: $129,500

Aggregate Commitments $

Platform

Title3Funds

Start Date

07/26/2021

Close Date

07/19/2022

Min. Goal

$100,000

Max. Goal

$1,070,000

Min. Investment

$500

Security Type

Equity - Common

Funding Type

RegCF

Series

Seed

Pre-Money Valuation

$25,102,770

Rolling Commitments $

Status

Active

Reporting Date

09/18/2021

Days Remaining

304

% of Min. Goal

130%

% of Max. Goal

12%

Likelihood of Max
possible
Avg. Daily Raise

$2,398

Momentum
cold
Log in or create a free account today to gain access to KingsCrowd analytics.
Location

Eugene, Oregon

Industry

Healthcare & Pharmaceuticals

Tech Sector

Biotech

Distribution Model

B2B

Margin

High

Capital Intensity

High

Business Type

Growth

Enosi Life Sciences, with a pre-money valuation of $25.1 million, is raising funds on Title3Funds. It is a drug research and development company focused on creating therapeutics for autoimmune diseases and cancer. The company aims to discover less toxic and more effective treatments that attack only the diseased cells and not the healthy ones. Dr. Jim Woody, Dr. Michael Shepard, and Sir Marc Feldmann founded Enosi Life Sciences in January 2020. The proceeds of the current crowdfunding round, with a minimum target of $100,000 and a maximum target of $1,070,000, will be used to make significant progress, carry out the laboratory proof of concept studies, and perform the clinical trials. Enosi Life Sciences has a unique approach to combine the discovery technologies used in cancer treatments and autoimmune disease treatments and employ them in both conditions.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-1,068,482

$-397,306

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$161,839

$578

Accounts Receivable

$0

$0

Total Assets

$1,341,234

$1,187,974

Short-Term Debt

$50,425

$319,955

Long-Term Debt

$53,667

$45,401

Total Liabilities

$104,092

$365,356

Financials as of: 07/26/2021
Log in or create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Starter

$8.33 /month
billed annually
Free portfolio tracking. Limited reports and filters.
Plan Includes:
Everything in Free, plus
Advanced company search ( limited filters)
Founder profiles and exclusive webinars
2 Analyst Reports per month
Get Starter Annual

Pro

$25 /month
billed annually
Unlimited analyst reports and market analytics.
Plan Includes:
Everything in Starter, plus
Full access to all Analyst Reports
Filter on Staff Picks (e.g. Top Deal, Deal to Watch, etc.)
Market Analytics
Get Pro Annual

Merlin

$41.67 /month
billed annually
Full site access including Merlin ratings.
Plan Includes:
Everything in Pro, plus
Search and filter companies by Merlin ratings
Company specific Merlin rating and risk assessment
Get Merlin Annual
Already a member? Log in here.

Ratings

Analyst Report

Other Deals

Covira Surgical on StartEngine 2021

The biotech company is focused on novel therapeutic alternatives to reduce post-surgical infections. The procedures of Covira Surgical leverage the…

Valuation: $9,987,500
Min Investment: $250
Industry: Healthcare & Pharmaceuticals
Raised $185,557 of $1,070,000 max
RegCF

Fluo Labs on StartEngine 2021

The medical device of Fluo Labs uses light therapy to relieve patients of their allergy symptoms without the use of…

Valuation: $12,000,000
Min Investment: $250
Industry: Healthcare & Pharmaceuticals
Raised $84,504 of $3,800,000 max
RegCF

Actipulse Neuroscience on Republic 2021

The business also aims to bring non-invasive treatment to patients’ homes. Adrien Chatillon founded Actipulse Neuroscience in June 2019. The…

Valuation Cap: $10,000,000
Min Investment: $100
Industry: Healthcare & Pharmaceuticals
Raised $92,426 of $1,070,000 max
RegCF

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Add Enosi Life Sciences on Title3Funds

Follow company

Follow Enosi Life Sciences on Title3Funds